We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $268M
1-Year Est. Return 158.98%
This Fund
S&P 500
This Quarter Est. Return
+39.3%
1 Year Est. Return
+158.98%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$223M
AUM Growth
+$77.2M
Cap. Flow
+$48M
Cap. Flow %
21.55%
Top 10 Hldgs %
25.3%
Holding
464
New
223
Increased
67
Reduced
60
Closed
103

Sector Composition

1 Healthcare 52.36%
2 Technology 13.57%
3 Financials 11.27%
4 Communication Services 4.48%
5 Energy 3.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNC icon
1
Centene
CNC
$32.8B
$9.07M 4.08%
220,530
-9,014
-4% -$337K
MOH icon
2
Molina Healthcare
MOH
$11.7B
$8.9M 4%
+51,285
New +$8.43M
ELV icon
3
Elevance Health
ELV
$80.9B
$8.08M 3.63%
23,039
+15,233
+195% +$5.15M
INTC icon
4
Intel
INTC
$478B
$5.34M 2.4%
144,840
+112,840
+353% +$4.26M
AXTI icon
5
AXT Inc
AXTI
$3B
$5.03M 2.26%
+307,611
New +$2.97M
TERN
6
DELISTED
Terns Pharmaceuticals
TERN
$4.59M 2.06%
113,555
+39,190
+53% +$906K
SNDK
7
Sandisk
SNDK
$201B
$4.28M 1.92%
+18,047
New +$3.61M
ABVX
8
Abivax
ABVX
$11.9B
$3.86M 1.73%
24,413
+14,809
+154% +$1.62M
JNJ icon
9
Johnson & Johnson
JNJ
$609B
$3.66M 1.65%
+17,708
New +$3.5M
BTSG icon
10
BrightSpring Health Services
BTSG
$13.9B
$3.52M 1.58%
93,897
+17,837
+23% +$598K
VKTX icon
11
Viking Therapeutics
VKTX
$4.31B
$3.18M 1.43%
90,514
+45,936
+103% +$1.63M
NVDA icon
12
NVIDIA
NVDA
$4.91T
$3.05M 1.37%
16,342
+4,728
+41% +$880K
GOOG icon
13
Alphabet (Google) Class C
GOOG
$4.22T
$2.53M 1.14%
+8,069
New +$2.31M
NBIS
14
Nebius Group N.V.
NBIS
$45.1B
$2.51M 1.13%
30,000
BMRN icon
15
BioMarin Pharmaceuticals
BMRN
$11.5B
$2.33M 1.04%
39,135
-9,731
-20% -$530K
NXE icon
16
NexGen Energy
NXE
$5.82B
$2.24M 1.01%
243,529
-5,823
-2% -$51.4K
REGN icon
17
Regeneron Pharmaceuticals
REGN
$70.9B
$2.11M 0.95%
2,731
-4,180
-60% -$2.84M
EHAB
18
DELISTED
Enhabit
EHAB
$2.1M 0.94%
227,806
+42,212
+23% +$366K
LITE icon
19
Lumentum
LITE
$57B
$2.09M 0.94%
+5,670
New +$1.46M
GPCR icon
20
CALL
Structure Therapeutics
GPCR
$3.45B
$1.96M 0.88%
+512
New +$20.9K
PDD icon
21
Pinduoduo
PDD
$120B
$1.86M 0.84%
16,423
-5,432
-25% -$674K
EGO icon
22
Eldorado Gold
EGO
$7.28B
$1.81M 0.81%
50,335
-7,976
-14% -$239K
CVS icon
23
CVS Health
CVS
$137B
$1.78M 0.8%
22,431
-29,111
-56% -$2.29M
CCB icon
24
Coastal Financial
CCB
$1.2B
$1.77M 0.79%
15,436
+6,345
+70% +$692K
TBBK icon
25
The Bancorp
TBBK
$2.85B
$1.71M 0.77%
25,259
+18,440
+270% +$1.27M

Similar funds

Persistent Asset Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Persistent Asset Partners held 464 positions worth $223M, up 53% from $145M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Persistent Asset Partners deployed $48M of net new capital in Q4 2025, opening 223 new positions and adding to 67 existing holdings. Its largest new stake was Molina Healthcare: 51,285 shares worth $8.9M.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 49% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was UnitedHealth, an estimated $3.15M trimmed.

  • Persistent Asset Partners's largest Q4 2025 buy was Molina Healthcare: 51,285 shares worth $8.9M.
  • Persistent Asset Partners added most to Elevance Health in Q4 2025, an estimated $5.15M increase.
  • Persistent Asset Partners's biggest Q4 2025 reduction was UnitedHealth, cutting an estimated $3.15M.
  • Persistent Asset Partners fully exited iShares 7-10 Year Treasury Bond ETF in Q4 2025, selling an estimated $4.82M.
  • Persistent Asset Partners's ten largest holdings make up 25% of its $223M portfolio in Q4 2025.
  • Persistent Asset Partners opened 223 new positions and closed 103 in Q4 2025.
  • Persistent Asset Partners's portfolio value rose 53% quarter-over-quarter to $223M.

Based on Persistent Asset Partners's 13F filing for Q4 2025, filed 17 Feb 2026.